Acute bacterial meningitis in adults F McGill, RS Heyderman, S Panagiotou, AR Tunkel, T Solomon The Lancet 388 (10063), 3036-3047, 2016 | 320 | 2016 |
Therapeutic benefits of nanoparticles in stroke S Panagiotou, S Saha Frontiers in neuroscience 9, 182, 2015 | 57 | 2015 |
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin LC Jacques, S Panagiotou, M Baltazar, M Senghore, S Khandaker, R Xu, ... Nature communications 11 (1), 1892, 2020 | 49 | 2020 |
A novel dynamic multicellular co-culture system for studying individual blood-brain barrier cell types in brain diseases and cytotoxicity testing P Miranda-Azpiazu, S Panagiotou, G Jose, S Saha Scientific Reports 8 (1), 8784, 2018 | 47 | 2018 |
Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa L Bricio-Moreno, VH Sheridan, I Goodhead, S Armstrong, JKL Wong, ... Nature communications 9 (1), 2635, 2018 | 41 | 2018 |
SARS-CoV-2 vaccines: fast track versus efficacy D Alkandari, JA Herbert, MA Alkhalaf, C Yates, S Panagiotou The Lancet Microbe 2 (3), e89-e90, 2021 | 30 | 2021 |
Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity S Panagiotou, C Chaguza, R Yahya, T Audshasai, M Baltazar, L Ressel, ... Scientific reports 10 (1), 17313, 2020 | 14 | 2020 |
Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection J Clarke, M Baltazar, M Alsahag, S Panagiotou, M Pouget, WA Paxton, ... Scientific Reports 11 (1), 19011, 2021 | 8 | 2021 |
Immune response to viruses JA Herbert, S Panagiotou Encyclopedia of infection and immunity, 429, 2022 | 7 | 2022 |
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin. Nat Commun 11: 1892 LC Jacques, S Panagiotou, M Baltazar, M Senghore, S Khandaker, R Xu, ... | 7 | 2020 |
Streptococcus pneumoniae rapidly translocate from the nasopharynx through the cribriform plate to invade the outer meninges T Audshasai, JA Coles, S Panagiotou, S Khandaker, HE Scales, M Kjos, ... Mbio 13 (4), e01024-22, 2022 | 6 | 2022 |
Fungal diversity in the soil Mycobiome: Implications for ONE health A Yiallouris, ZD Pana, G Marangos, I Tzyrka, S Karanasios, I Georgiou, ... One Health, 100720, 2024 | 3 | 2024 |
Streptococcus pneumoniae rapidly translocates from the nasopharynx through the cribriform plate to invade and inflame the dura T Audshasai, JA Coles, S Panagiotou, S Khandaker, HE Scales, M Kjos, ... bioRxiv, 2021.09. 28.462246, 2021 | 2 | 2021 |
The University of Manchester S Panagiotou United Kingdom, 0 | 2 | |
Therapeutic benefits of nanoparticles in stroke. S Saha, S Panagiotou Frontiers in Cellular Neuroscience, 2015 | 1 | 2015 |
Novel composition A Kadioglu, M Yang, S Panagiotou US Patent App. 18/270,947, 2024 | | 2024 |
The effect of COVID-19 on our lifestyle and microbiome: What could long term imbalanced diet and germophobia mean for our immunity? M Almadhi, S Gharaei, JA Herbert, MA Alkhalaf, K Kahlat, C Yates, ... Hygiene and environmental health advances 5, 100046, 2023 | | 2023 |
Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity (vol 10, 17313, 2020) S Panagiotou, C Chaguza, R Yahya, T Audshasai, M Baltazar, L Ressel, ... SCIENTIFIC REPORTS 12 (1), 5099-, 2022 | | 2022 |
Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity S Panagiotou, C Chaguza, R Yahya, T Audshasai, M Baltazar, L Ressel, ... Scientific Reports 12, 2022 | | 2022 |
Method for detecting the presence of one or more bacterial toxins in a biological fluid using liposomes A Kadioglu, D Neill, S Panagiotou US Patent App. 16/612,198, 2021 | | 2021 |